Neoantigen Peptide Synthesis

Neoantigen peptides are short chains of amino acids that are derived from tumor-specific mutated proteins. Neoantigens are unique to cancer cells and are not found in normal cells, making them promising targets for cancer immunotherapy. In recent years, precision immunotherapy targeting neoantigens has gradually become a research hotspot, especially in the field of tumor vaccines and antiviral vaccines. Many new therapeutic modalities, including personalized vaccines and cell therapies, are emerging. Among them, tumor personalized peptide vaccines targeting neoantigens are an important branch of the new precision immunotherapy. In order to meet the growing demand of customers in the field of neoantigens, Alfa Chemistry, with its rich experience in peptide synthesis, has created a one-stop synthesis service for neoantigen peptides.

What We Offer

Alfa Chemistry have expertise in synthesizing neoantigen peptides for various applications, such as cancer immunotherapy, and personalized medicine. Our team of experts uses state-of-the-art technology and cutting-edge methodologies to ensure the successful synthesis of neoantigen peptides to meet the requirements of our clients. As a biotechnology company specializing in peptide synthesis, Alfa Chemistry provide a range of services related to neoantigen peptide synthesis, including:

• Neoantigen prediction and selection
• Neoantigen peptide design and synthesis
• Neoantigen peptide high-throughput synthesis
• Neoantigen peptide library synthesis
• Preclinical services for neoantigen peptides
• Neoantigen peptide investigational new drug (IND) filing
• ...

Overall, our goal is to provide comprehensive neoantigen peptide synthesis services to support your research and drug development needs. Contact us to learn more about our neoantigen peptide synthesis services and how we can support your research and development projects.

Neoantigen Peptide Applications

Neoantigen peptides have several potential applications in the fields of cancer immunotherapy, vaccine development, etc. Some of the key applications include:

• Cancer immunotherapy. Neoantigen peptides are used in cancer immunotherapy to stimulate the immune system to recognize and attack tumor cells expressing these specific antigens.
• Personalized cancer vaccines. Neoantigen peptides can be incorporated into personalized cancer vaccines designed to target the unique mutations present in an individual's tumor cells. These vaccines can potentially elicit a robust and specific immune response against the tumor, while minimizing off-target effects.
• Biomarkers for cancer diagnosis and prognosis. Neoantigen peptides can serve as biomarkers for cancer diagnosis and prognosis. The presence of specific neoantigens in tumor cells can indicate the likelihood of response to immunotherapy, disease progression, and overall patient outcome.
• Drug target identification. Neoantigen peptides can also be used to identify potential drug targets for cancer therapy. Targeting neoantigens specific to tumor cells can lead to the development of novel therapeutic strategies that selectively kill cancer cells while sparing normal tissues.

Our Advantages

Service Process